To evaluate the effect of a Persian medicine product, containing silk, on the incidence of pregnancy in infertile women with polycystic ovary syndrom
- Conditions
- Infertility in women with polycystic ovary syndrome.Female infertility associated with anovulationN97.0
- Registration Number
- IRCT20221009056122N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 58
Infertile women suffering from polycystic ovary syndrome referred to Rehane Infertility Center, Nekoui Hospital, Qom.
Informed consent to enter the plan
The period of infertility is at least 1 year and at most 5 years
BMI less than 30 kg/m2
Male factor Infertility
Tubular infertility
other types of ovarian cysts except for PCO
Endometriosis Premature ovarian failure (POF) and decreased ovarian reserve (DOR)
Underlying and systemic disease and malignancy Breast diseases such as breast cysts Liver, kidney, joint and rheumatic disorders Other diseases including metabolic diseases such as diabetes and endocrine disorders including uncontrolled hypothyroidism, hyperprolactinemia, and Cushing's disease
Breast diseases such as breast cysts
Liver, kidney, joint and rheumatic disorders Other diseases including metabolic diseases such as diabetes and endocrine disorders including uncontrolled hypothyroidism, hyperprolactinemia, and Cushing's disease
Other diseases include metabolic diseases such as diabetes and endocrine disorders including uncontrolled hypothyroidism, hyperprolactinemia, and Cushing's disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Chemical pregnancy. Timepoint: After the first delay in menstruation, the fourth week of the menstruation cycle. Method of measurement: Serum ?-hCG meausurment.
- Secondary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: After a positive serum ?-hCG test, the fifth to sixth week of the menstruation cycle. Method of measurement: Observing fetal heart rate on ultrasound.;The level of anxiety. Timepoint: The beginning and end of the intervention. Method of measurement: Anxiety score in Beck's questionnaire.